The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials.

Mocko, Pawel; Sladowska, Katarzyna; Kawalec, Pawel; Babii, Yana; Pilc, Andrzej

Mocko, Pawel; Sladowska, Katarzyna; Kawalec, Pawel; Babii, Yana; Pilc, Andrzej.

Afiliação

Mocko P; Health Policy and Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.
Sladowska K; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.
Kawalec P; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.
Babii Y; Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Kraków, Poland.
Pilc A; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Skawinska 8, 31-066 Kraków, Poland.

Biomedicines ; 11(10)2023 Sep 26.

Article em En | MEDLINE | ID: mdl-37893010

Palavras-chave

MDD; RCT; antidepressant; antimuscarinics; clinical trial; depression; hyoscine; major depressive disorder; muscarinic antagonists; randomized controlled trial; scopolamine; systematic review

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Biomedicines Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google